| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The lancet 396 (10258), 1204-1222, 2020 | 7035 | 2020 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to … C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ... JAMA oncology 3 (4), 524-548, 2017 | 7022 | 2017 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 5392 | 2020 |
| Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic … H Wang, KM Abbas, M Abbasifard, M Abbasi-Kangevari, H Abbastabar, ... The Lancet 396 (10258), 1160-1203, 2020 | 1178 | 2020 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to … Global Burden of Disease Cancer Collaboration JAMA oncology 3 (4), 524, 2017 | 670 | 2017 |
| Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 577 | 2020 |
| Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global … R Lozano, N Fullman, JE Mumford, M Knight, CM Barthelemy, C Abbafati, ... The Lancet 396 (10258), 1250-1284, 2020 | 531 | 2020 |
| Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic … MB Reitsma, PJ Kendrick, E Ababneh, C Abbafati, M Abbasi-Kangevari, ... The Lancet 397 (10292), 2337-2360, 2021 | 445 | 2021 |
| Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017 SL James, CD Castle, ZV Dingels, JT Fox, EB Hamilton, Z Liu, ... Injury Prevention 26 (Suppl 2), i96-i114, 2020 | 407* | 2020 |
| How big data and artificial intelligence can help better manage the COVID-19 pandemic NL Bragazzi, H Dai, G Damiani, M Behzadifar, M Martini, J Wu International journal of environmental research and public health 17 (9), 3176, 2020 | 403 | 2020 |
| Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life TV Nguyen, G Damiani, LAV Orenstein, I Hamzavi, GB Jemec Journal of the European Academy of Dermatology and Venereology 35 (1), 50-61, 2021 | 234 | 2021 |
| Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 D Bryazka, MB Reitsma, MG Griswold, KH Abate, C Abbafati, ... The Lancet 400 (10347), 185-235, 2022 | 222 | 2022 |
| Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis) AV Marzano, G Damiani, I Ceccherini, E Berti, M Gattorno, M Cugno British Journal of Dermatology 176 (6), 1588-1598, 2017 | 184 | 2017 |
| The global, regional, and national burden of psoriasis: results and insights from the global burden of disease 2019 study G Damiani, NL Bragazzi, C Karimkhani Aksut, D Wu, G Alicandro, ... Frontiers in medicine 8, 743180, 2021 | 137 | 2021 |
| Biologics increase the risk of SARS‐CoV‐2 infection and hospitalization, but not ICU admission and death: real‐life data from a large cohort during red‐zone declaration G Damiani, A Pacifico, NL Bragazzi, P Malagoli Dermatologic therapy 33 (5), e13475, 2020 | 135 | 2020 |
| Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype … A Watad, NL Bragazzi, D McGonagle, M Adawi, C Bridgewood, ... Clinical Immunology 203, 1-8, 2019 | 129 | 2019 |
| Efficacy and tolerability of bevacizumab in patients with severe Covid-19 J Pang, F Xu, G Aondio, Y Li, A Fumagalli, M Lu, G Valmadre, J Wei, ... Nature communications 12 (1), 814, 2021 | 124 | 2021 |
| Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 JL Ward, PS Azzopardi, KL Francis, JS Santelli, V Skirbekk, SM Sawyer, ... The Lancet 398 (10311), 1593-1618, 2021 | 123 | 2021 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 EM Alvarez, LM Force, R Xu, K Compton, D Lu, HJ Henrikson, ... The Lancet Oncology 23 (1), 27-52, 2022 | 118 | 2022 |
| Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease … RC Reiner, KE Wiens, A Deshpande, MM Baumann, PA Lindstedt, ... The Lancet 395 (10239), 1779-1801, 2020 | 113 | 2020 |
